Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Ductal, Breast 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tumor Response Rate 1Thrombosis 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Therapy 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Nasopharyngeal Cancer Recurrent 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Sirtuins 1Radiotherapy, Conformal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Tumor Response Rate × Radiotherapy, Conformal × Clear all
NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown
2,000 enrolled

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon âš¡